Catalina Becerril-Trejo
Mexico City, DIF, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Liquid Biopsy in Primary CNS Tumors: Bridging Biology, Technology, and Clinical Care.
Journal: Molecular diagnosis & therapy
Published: January 29, 2026
Germline Genetic Variants in Cancer Predisposition Genes in Patients From Latin America and the Caribbean.
Journal: JCO global oncology
Published: April 18, 2025
Somatic Landscape of Oncogenic Variants Across the Main Cancer Subtypes in Latin America: A Narrative Review.
Journal: JCO global oncology
Published: February 28, 2025
Increased amounts of cell-free DNA released from a culture with a high content of cancer stem cells.
Increased amounts of cell-free DNA released from a culture with a high content of cancer stem cells.
Journal: Frontiers in cell and developmental biology
Published: September 22, 2024
TP53 oncogenic variants as prognostic factors in individuals with glioblastoma: a systematic review and meta-analysis.
Journal: Frontiers in neurology
Published: September 02, 2024
The non-vesicle cell-free DNA (cfDNA) induces cell transformation associated with horizontal DNA transfer.
Journal: Molecular biology reports
Published: August 30, 2023
Hereditary diffuse gastric cancer (HDGC). An overview.
Journal: Clinics and research in hepatology and gastroenterology
Published: May 26, 2021
The role of extracellular DNA (exDNA) in cellular processes.
Journal: Cancer biology & therapy
Published: April 16, 2021
Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells.
Journal: OncoTargets and therapy
Published: December 26, 2018
Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy.
Journal: Expert opinion on investigational drugs
Published: May 04, 2018
Viral inhibitors of NKG2D ligands for tumor surveillance.
Journal: Expert opinion on therapeutic targets
Published: June 21, 2016
Last Updated: 09/26/2026